Use of Complementary and Integrative Medicine Among Patients With Glioblastoma Multiforme Seen at a Tertiary Care Center

• Main Authors: Amanda Munoz-Casabella MD (Author), Dietlind L. Wahner-Roedler MD (Author), Ivana T. Croghan PhD (Author), Tanya M. Petterson MS (Author), Debbie L. Fuehrer LPCC (Author), Brent A. Bauer MD (Author)
• Format: Book
• Published: SAGE Publishing, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Glioblastoma multiforme (GBM) is among the most aggressive and lethal tumors, with a median survival of 12-15 months. Many patients use complementary and integrative medicine (CIM) therapies to supplement their cancer treatment. Objective To determine the prevalence of CIM use and identif...